BioCentury
ARTICLE | Clinical News

TOBI Podhaler regulatory update

July 16, 2012 7:00 AM UTC

FDA's Anti-Infectives Drugs Advisory Committee will meet on Sept. 5 to discuss an NDA from Novartis for TOBI Podhaler to treat Pseudomonas aeruginosa lung infections in cystic fibrosis patients. Novar...